Haemonetics Expects 2024 Revenue Growth Of 5%-8% On Reported Basis And 0%-3% On Organic Basis
Haemonetics Expects 2024 Revenue Growth Of 5%-8% On Reported Basis And 0%-3% On Organic Basis
Haemonetics預計，2024年的收入在報告基礎上將增長5％-8％，有機收入增長0％-3％
Haemonetics Expects 2024 Revenue Growth Of 5%-8% On Reported Basis And 0%-3% On Organic Basis
Haemonetics預計，2024年的收入在報告基礎上將增長5％-8％，有機收入增長0％-3％
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。